Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Adaptyx, Alexion, Ani, Alfasigma, Amneal, Aquestive, Astrazeneca, Bayer, Bone Support, Corcept, Cordis, Daiichi, Eli Lilly, Emanate, Enable, Fempulse, Filana, Glycomine, Impact, Insmed, Intrabio, J&J, Kedrion, Koning, Lantheus, Leo, Maat, Merck, Merz, Natera, Net, Newamsterdam, Novartis, Novo, Nuvation, Oncopeptides, Pattern, Pharmanovia, Phast, Pr